Showing 1 - 10 of 13,933
AFP, Published on 18/07/2025
» AYLMER — In the Canadian town of Aylmer, where Mennonites in traditional dress walk down the main street alongside secular locals, bitter divisions over vaccine scepticism that arose during the coronavirus 2019 (Covid-19) pandemic have intensified with the reemergence of measles.
News, Mongkol Bangprapa, Published on 13/07/2025
» The government confirmed there have been 40 confirmed cases of monkeypox in Thailand so far this year, with officials urging vigilance, particularly among high-risk groups and travellers returning from affected regions.
Oped, Postbag, Published on 10/07/2025
» Re: "20-baht flat rate fare gets the nod", (BP, July 9).
Published on 07/07/2025
» Bangkok, July 7, 2025 — As Thailand transitions from the rainy to early winter seasons, respiratory infections surge dramatically, making awareness and proper prevention crucial. Recognising this urgent public health concern, Sanofi Thailand supported a vital Health Talk session at Thailand Healthcare 2025 under the topic: "Infants Catch It Easily, the Elderly are at High Risk: Understanding RSV and Influenza." The session featured distinguished medical experts Prof. Dr. Sasisopin Kiertiburanakul and Assoc. Prof. Dr. Sophida Boonsathorn Reeves, infectious disease specialists from the Faculty of Medicine, Ramathibodi Hospital, Mahidol University. They shared comprehensive knowledge and strategic prevention approaches to protect families, with particular focus on the most vulnerable groups: newborns, infants, and seniors aged 65 and above.
News, Peerasit Kamnuansilpa, Published on 05/07/2025
» In the decades ahead, Thailand will not collapse in a blaze of war, disease, or climate catastrophe. Rather, it will quietly wither from within. The twin forces of demographic decline and digital automation are converging with astonishing speed, and yet our political and moral imaginations remain unprepared.
News, Apinya Wipatayotin, Published on 04/07/2025
» The Government Pharmaceutical Organisation (GPO) has prepared to register the affordable hepatitis C drug ravidasvir with the Food and Drug Administration to improve access for 800,000 patients and reduce treatment costs.
Oped, Editorial, Published on 30/06/2025
» The recent news of Gilead Sciences' groundbreaking new HIV preventative drug, Lenacapavir, offers a beacon of hope in the fight against HIV. With a remarkable 96% efficacy in reducing HIV infection and the convenience of only two injections per year, Lenacapavir holds the potential to be a true game-changer in the global effort to halt the transmission of HIV.
AFP, Published on 20/06/2025
» SHANGHAI - Small, fuzzy and baring sharp teeth, Chinese toymaker Pop Mart's Labubu monster dolls have taken over the world, drawing excited crowds at international stores and adorning the handbags of celebrities such as Rihanna and Cher.
Guru, Nianne-Lynn Hendricks, Published on 19/06/2025
» New releases that hit cinemas in Thailand this week.
AFP, Published on 19/06/2025
» WASHINGTON - The US Food and Drug Administration on Wednesday approved Gilead Sciences’ twice-yearly injection to prevent HIV — a move the company hailed as a major breakthrough in the fight against the sexually transmitted virus.